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PUTTING PEOPLE WITH PARKINSON’S IN CONTROL: EXPLORING 
THE IMPACT OF QUALITY SOCIAL CARE 
 
INTRODUCTION 
Parkinson’s is a progressive and incurable condition. It is the second most common 
neurodegenerative condition in the UK.  There are approximately 127,000 people with 
Parkinson’s in the UK. This number is expected to increase as people live longer.  
 
Cost-effective social care services are a priority in the future delivery of adult social care. This 
study aimed to explore how the provision of quality social care interventions impacts on quality 
of life, health and wellbeing and future care costs for people with Parkinson’s and their carers.  
 
In the current period of austerity, there are now increasing cuts to services such as carers’ 
breaks and advocacy services and reduced access to aids and adaptations. Many local 
authorities are tightening service eligibility criteria.  
 
Social care includes a variety of interventions such as personal care at home, support for the 
person's carer, Telecare, aids and adaptations at home or support to engage in hobbies and 
interests outside the home.  Social care can be provided by a number of different agencies 
including formal care provider organisations as well as family and friends.  
 
This report presents the findings from a research project conducted by Sheffield Hallam 
University and in partnership with Parkinson’s UK.  Parkinson’s UK is a national charity which 
aims to improve life for everyone affected by Parkinson’s. 
 
 
METHODS 
The study was conducted in three stages and adopted case study, individual interview and 
focus group methods. 
 
The research developed insight into social care needs and requirements, criteria for a 
segmentation model, pen portraits, an economic model, and a communications strategy. These 
are all available in the full report from Parkinson's UK. 
 
KEY FINDINGS 
Finding out and accessing what’s available 
There was a consistent theme that people with Parkinson's did not know what was available or 
how to access it in terms of social care. 
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What’s important about social care  
Control, choice and maintaining independence emerged as important aspects of social care for 
all. Valued aspects of social care that were specific to Parkinson's requirements were that 
services:  
 Understand Parkinson’s 
 Understand medication (especially timing) 
 Allow the person with Parkinson’s time 
 Understand the person with Parkinson's is the expert 
 Recognise the impact of social inclusion 
 Have regular reassessment of needs relating to Parkinson's symptoms and 
treatment 
 
Benefits of social care 
Benefits of social care were interrelated - for example if there is a benefit to the person with 
Parkinson's (e.g. improved safety) this might reduce the burden for the carer, or result in the 
avoidance of wider societal costs such as residential care or hospital admissions.  While some 
of the benefits take immediate effect, some of these benefits also have long term implications 
and can result in prevented events and reductions in the need for increased health and social 
care resource in the future. 
 
The Impact Gap 
The study developed the concept of the ‘Impact Gap’ illustrating how the costs of social care 
can be reduced by the timeliness and quality of "Parkinson's aware" social care.  
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KEY RECOMMENDATIONS 
Key recommendations included implications for commissioners and providers of social care 
services. The overarching recommendations were as follows.  
1. Commissioners and providers should ensure that people with Parkinson's receive good 
quality social care that maximises control, self-management, independence and social 
contact.  
 
2. There should be an anticipatory approach to social care provision and commissioning 
that ensures timely access and receipt of social care for people with Parkinson's and 
their carers. The benefits are: 
 prevention of avoidable events 
 prevented or delayed admission to residential care homes 
 averting crisis 
 more accurate prediction of future care and resource requirements through better 
care planning  
 reduced health and social care costs 
 improved patient and service user experience 
 
3. Social care for people with Parkinson's and their carers should be characterised by 
control and choice for the service user.  This is irrespective of whether the care package 
is managed directly by the person with Parkinson's or their carer or provided by an 
outside agency. 
 
4. Service user experience should be a key performance indicator to inform the allocation 
and renewal of care provider contracts for patients with Parkinson's and similar 
neurological conditions. 
 
 
CONCLUSION 
The research demonstrated very powerfully the need for care packages sympathetic to those 
with neurological disorders such as Parkinson’s.  It explored how this impacted on their quality 
of life and wellbeing and what this could mean in terms of the escalating need for, and the cost 
of care.   
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